Improvements In The Treatment Of CTCL
Tatyana Feldman, MD, Hematology & Oncology, Hackensack University Medical Center, John Theurer Cancer Center, discusses Improvements In The Treatment Of CTCL. At The 60th ASH Annual Meeting on Dec 1, ... Author: obr Added: 01/15/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 15, 2019 Category: Cancer & Oncology Source Type: podcasts

Improvements In The Treatment Of CTCL
Swaminathan P. Iyer, MD, Professor, Department of Lymphoma and Myeloma, Division of Cancer Medicine Division, MD Anderson Cancer Center, Discusses Improvements In The Treatment Of CTCL. At The 60th AS... Author: obr Added: 01/15/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 15, 2019 Category: Cancer & Oncology Source Type: podcasts

Chlormethine gel: opinion on potential approval and usage in Europe
Topical alkylating agents have proven beneficial in treating patients with mycosis fungoides (MF). Here, Martine Bagot, MD, PhD, of Saint Louis Hospital, Paris, France, discusses this topic at the Eur... Author: VJHemOnc Added: 10/02/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 2, 2018 Category: Cancer & Oncology Source Type: podcasts

Mogamulizumab: an exciting antibody for autoimmunity
Martine Bagot, MD, PhD, of Saint Louis Hospital, Paris, France, discusses the exciting new approval of the antibody mogumulizumab for cutaneous T-cell lymphoma. Speaking at the European Organisation f... Author: VJHemOnc Added: 10/02/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 2, 2018 Category: Cancer & Oncology Source Type: podcasts

First-in-human study of IPH4102 for relapsed cutaneous T-cell lymphoma
Martine Bagot, MD, PhD, of Saint Louis Hospital, Paris, France, speaks at the European Organisation for the Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force (CLTF) 2018 Congress,... Author: VJHemOnc Added: 10/02/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 2, 2018 Category: Cancer & Oncology Source Type: podcasts

Resminostat maintenance for advanced cutaneous lymphoma: RESMAIN study
Maintenance therapy options for cutaneous T-cell lymphomas could be improved. Here, Rudolf Stadler, MD, PhD, of the University Medical Center Minden, Minden, Germany, discusses the RESMAIN study (NCT0... Author: VJHemOnc Added: 10/02/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 2, 2018 Category: Cancer & Oncology Source Type: podcasts

Clinical scoring system for Szary syndrome: results from a retrospective study
An accurate and optimized clinical scoring system is essential for the staging and management of cutaneous T-cell lymphoma. Here, Pietro Quaglino, MD, of the University of Turin, Turin, Italy, discuss... Author: VJHemOnc Added: 10/02/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 2, 2018 Category: Cancer & Oncology Source Type: podcasts

PROCLIPI: registry & establishment of a prognostic index for MF and SS
Establishing a registry and prognostic index for mycosis fungoides, the most common type of cutaneous T-cell lymphoma (CTCL), and Szary syndrome, a rare type of CTCL, is important to improve the mana... Author: VJHemOnc Added: 10/02/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 2, 2018 Category: Cancer & Oncology Source Type: podcasts

CD47-blocking checkpoint inhibitor TTI-621 shows promising results for cutaneous T-cell lymphomas
A novel CD47-blocking checkpoint inhibitor has shown promising interim results in a multicenter Phase I trail for relapsed/refractory mycosis fungoides and Szary syndrome, the most common types of cu... Author: VJHemOnc Added: 10/02/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 2, 2018 Category: Cancer & Oncology Source Type: podcasts

Improved understanding of CTCL disease biology
Pierluigi Porcu, MD, from the Sidney Kimmel Cancer Center, Philadelphia, PA, discusses recent clinical developments that have provided healthcare professionals with a clear landscape of the disease. D... Author: VJHemOnc Added: 09/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 28, 2018 Category: Cancer & Oncology Source Type: podcasts

Promising treatments in CTCL
With new targets identified over the past few years, the development of precision medicine has expanded significantly. Speaking from the 2018 Society of Hematologic Oncology (SOHO) Annual Meeting in H... Author: VJHemOnc Added: 09/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 28, 2018 Category: Cancer & Oncology Source Type: podcasts

Challenges in diagnosing and treating CTCL
With cutaneous T-cell lymphoma (CTCL) being a rare disease with an incredibly high prevalence, Pierluigi Porcu, MD, from Sidney Kimmel Cancer Center, Philadelphia, PA, describes the challenges of CTCL... Author: VJHemOnc Added: 09/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 28, 2018 Category: Cancer & Oncology Source Type: podcasts

MAVORIC trial: mogamulizumab for R/R CTCL
At the 2018 Society of Hematologic Oncology (SOHO) Annual Meeting in Houston, TX, Pierluigi Porcu from Sidney Kimmel Cancer Center, Philadelphia, PA, describes the MAVORIC trial (NCT01728805) investig... Author: VJHemOnc Added: 09/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 28, 2018 Category: Cancer & Oncology Source Type: podcasts

Pre-clinical activity of tipifarnib in CTCL
Providing us with insight into a trial not yet published, Pierluigi Porcu, MD, from Jefferson Hospital, Sidney Kimmel Cancer Center, Philadelphia, PN, discusses his teams investigation into potential... Author: VJHemOnc Added: 09/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 21, 2018 Category: Cancer & Oncology Source Type: podcasts

Huge Need for Better Therapy for CTCL | Hope for FDA-Approval of Drug Based on Data
Pierluigi Porcu, MD, Thomas Jefferson University talks about a Huge Need for Better Therapy for CTCL | Hope for FDA-Approval of Drug Based on Data Author: Annual-Meeting Added: 06/20/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 21, 2018 Category: Cancer & Oncology Source Type: podcasts